Pharmacovigilance

Identification, assessment and prevention

Pharmacovigilance is a public health activity focused on the identification, assessment and prevention of adverse reactions for marketed drugs. An Adverse Reaction is defined as any undesirable effect which appears after the administration of a drug.

In order to achieve this goal, a close collaboration is required among the different parts involved in the use of the medicine (pharmaceutical companies, healthcare professionals, health authorities and patients or consumers).

In EXELTIS we have a commitment for improving health and quality of life of our patients and ensuring their safety. Thus, we have available a system for:

  • Reporting Adverse Drug Reactions
  • Continuous monitoring the safety profile of our drugs
  • Keeping the relevant health authorities informed and taking the appropriate measures

Contact details for Adverse Drug Reaction reporting:

Tel (24 hours): +34 628 651 773
Fax: +34 91 383 07 79
E-mail: pharmacovigilance@exeltis.com

Disclaimer

Pursuant to the provisions of Law 15/1999 of December 13, Protection of Personal Data (LOPD), Exeltis informs you that the personal data provided by you will be included in the PHARMACOVIGILANCE file, of which the company is responsible. These personal data are collected and stored in order to comply with legal requirements on reporting adverse drug reactions and for the evaluation of their benefit-risk balance. You can exercise your rights of access, rectification, cancellation and opposition to the processing of the data through written communication to the following address: Ebrosa Building. Manuel Pombo Angulo, 28 3th floor 28050 Madrid, Spain.